Publicacións (75) Publicacións nas que participase algún/ha investigador/a


  1. Effects of phytosterols and pholyphenols on prostate cancer models

    Electronic Journal of Environmental, Agricultural and Food Chemistry, Vol. 7, Núm. 8, pp. 3353-3355

  2. Corrigendum to "1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor" [Bioorg. Med. Chem. 16 (2008) 2852-2869] (DOI:10.1016/j.bmc.2008.01.002)

    Bioorganic and Medicinal Chemistry

  3. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles (Pharmaceutical Research DOI: 10.1007/s11095-007-9318-0)

    Pharmaceutical Research

  4. Actividades de referencia del Laboratorio Comunitario de Referencia de Biotoxinas Marinas

    Avances y tendencias en fitoplancton tóxico y biotoxinas: actas de la IX Reunión Ibérica sobre Fitoplancton Tóxico y Biotoxinas, Cartagena 7-10 de mayo de 2007

  5. Evaluation of various pH and temperature conditions on the stability of azaspiracids and their importance in preparative isolation and toxicological studies

    Analytical Chemistry, Vol. 80, Núm. 24, pp. 9672-9680

  6. Estudio de perfusión miocárdica en pacientes que no alcanzan la frecuencia submáxima en la ergometría

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 4, pp. 259-265

  7. El nombre de la rosa/ Der Name der Rose (1986): Aspectos básicos de la medicina-farmacia monacal en el medievo

    Revista de medicina y cine, Vol. 4, Núm. 2, pp. 41-46

  8. Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils

    Blood, Vol. 111, Núm. 4, pp. 1789-1795

  9. Dissolution rate enhancement of the novel antitumoral β-lapachone by solvent change precipitation of microparticles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 3, pp. 871-877

  10. Dendronised block copolymers as potential vectors for gene transfection

    Organic and Biomolecular Chemistry, Vol. 6, Núm. 11, pp. 1905-1911

  11. Cytotoxic effect of azaspiracid-2 and azaspiracid-2-methyl ester in cultured neurons: Involvement of the c-Jun N-terminal kinase

    Journal of Neuroscience Research, Vol. 86, Núm. 13, pp. 2952-2962

  12. Cytoskeletal toxicity of pectenotoxins in hepatic cells

    British Journal of Pharmacology, Vol. 155, Núm. 6, pp. 934-944

  13. Azaspiracid substituent at C1 is relevant to in vitro toxicity

    Chemical Research in Toxicology, Vol. 21, Núm. 9, pp. 1823-1831

  14. Assessment of the hydrolysis process for the determination of okadaic acid-group toxin ester: Presence of okadaic acid 7-O-acyl-ester derivates in Spanish shellfish

    Toxicon, Vol. 51, Núm. 5, pp. 765-773

  15. A new chemical tool (C0036E08) supports the role of adenosine A2B receptors in mediating human mast cell activation

    Biochemical Pharmacology, Vol. 76, Núm. 7, pp. 912-921

  16. A microtubule interactome: Complexes with roles in cell cycle and mitosis

    PLoS Biology, Vol. 6, Núm. 4, pp. 785-795

  17. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: Design, synthesis, and SAR studies

    Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 2, pp. 793-797

  18. 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor

    Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 6, pp. 2852-2869

  19. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: Design, synthesis, structure-affinity and structure-selectivity relationships

    Bioorganic and Medicinal Chemistry, Vol. 16, Núm. 22, pp. 9780-9789

  20. "Fluorescent glycogen" formation with sensibility for in vivo and in vitro detection

    Glycoconjugate Journal, Vol. 25, Núm. 6, pp. 503-510